← FDA Drug Approvals (Drugs@FDA)
LEVOCARNITINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2026-07-02
Drug application
- FDA Application #
ANDA217896- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVOCARNITINE
- Generic name
- LEVOCARNITINE
- Active ingredients
- LEVOCARNITINE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- BAXTER HLTHCARE CORP
- Manufacturer
- Baxter Healthcare Corporation
- First approval
- 2026-07-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown